» Articles » PMID: 33727658

Adiponectin-expressing Treg Facilitate T Lymphocyte Development in Thymic Nurse Cell Complexes

Overview
Journal Commun Biol
Specialty Biology
Date 2021 Mar 17
PMID 33727658
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Adiponectin is a well-known insulin sensitizer and anti-inflammatory molecule, possessing therapeutic potentials in cardiovascular, metabolic and cancer diseases. Results of the present study demonstrate that adiponectin is expressed in a population of regulatory T-cells (Treg) resided within the thymic nurse cell (TNC) complexes. Adoptive transfer of adiponectin-expressing Treg precursors effectively attenuated obesity, improved glucose and insulin tolerance, prevented fatty liver injuries in wild-type mice fed a high-fat diet, and significantly inhibited breast cancer development in MMTV-PyVT transgenic mice. Within the TNC complexes, locally produced adiponectin bound to and regulated the expression as well as the distribution of CD100, a transmembrane lymphocyte semaphorin, in turn modulating the lymphoepithelial interactions to facilitate T-cell development and maturation. In summary, adiponectin plays an important role in the selection and development of T lymphocytes within the TNC complexes. Adiponectin-expressing Treg represent a promising candidate for adoptive cell immunotherapy against obesity-related metabolic and cancer diseases.

Citing Articles

Immune regulation and organ damage link adiponectin to sepsis.

Zhang L, Lin Y, Zhang Z, Chen Y, Zhong J Front Immunol. 2024; 15:1444884.

PMID: 39664383 PMC: 11632310. DOI: 10.3389/fimmu.2024.1444884.


Impact of hyperglycemia on immune cell function: a comprehensive review.

Lee H, Kim M, Lee I, Hong C, Jeon J Diabetol Int. 2024; 15(4):745-760.

PMID: 39469566 PMC: 11512986. DOI: 10.1007/s13340-024-00741-6.


Thymus in Cardiometabolic Impairments and Atherosclerosis: Not a Silent Player?.

Kologrivova I, Naryzhnaya N, Suslova T Biomedicines. 2024; 12(7).

PMID: 39061983 PMC: 11273826. DOI: 10.3390/biomedicines12071408.


Implication of IZUMO2 in the cell-in-cell phenomenon: A potential therapeutic target for triple-negative breast cancer.

Higashi T, Saigo C, Chikaishi W, Hayashi H, Hanamatsu Y, Futamura M Thorac Cancer. 2024; 15(7):513-518.

PMID: 38258402 PMC: 10912533. DOI: 10.1111/1759-7714.15189.


Adiponectin-expressing Treg-containing T cell fraction inhibits tumor growth in orthotopically implanted triple-negative breast cancer.

Chikaishi W, Higashi T, Hayashi H, Hanamatsu Y, Futamura M, Matsuhashi N Thorac Cancer. 2023; 14(30):3058-3062.

PMID: 37674354 PMC: 10599968. DOI: 10.1111/1759-7714.15102.


References
1.
Wang Y, Lam K, Xu J, Lu G, Xu L, Cooper G . Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem. 2005; 280(18):18341-7. DOI: 10.1074/jbc.M501149200. View

2.
Yano H, Andrews L, Workman C, Vignali D . Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity. Immunology. 2019; 157(3):232-247. PMC: 6587321. DOI: 10.1111/imm.13067. View

3.
Shi H, Chi H . Metabolic Control of Treg Cell Stability, Plasticity, and Tissue-Specific Heterogeneity. Front Immunol. 2020; 10:2716. PMC: 6917616. DOI: 10.3389/fimmu.2019.02716. View

4.
Perry J, Hsieh C . Development of T-cell tolerance utilizes both cell-autonomous and cooperative presentation of self-antigen. Immunol Rev. 2016; 271(1):141-55. PMC: 4837647. DOI: 10.1111/imr.12403. View

5.
Takahama Y, Ohigashi I, Baik S, Anderson G . Generation of diversity in thymic epithelial cells. Nat Rev Immunol. 2017; 17(5):295-305. DOI: 10.1038/nri.2017.12. View